Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nursing considerations in brachytherapy-related erectile dysfunction.

Robin Stipetich1, Laura J Abel, Richard L Anderson

  • 1Schiffler Cancer Center, Wheeling, WV, USA.

Urologic Nursing
|October 18, 2005
PubMed
Summary

Brachytherapy for early prostate cancer can cause erectile dysfunction (ED), contrary to prior assumptions. Factors like pre-treatment function and radiation dose influence ED, but most cases respond to oral medications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting Critical Micelle Concentrations from Short Time Scale Simulations.

The journal of physical chemistry. B·2025
Same author

A dataset for aqueous surfactant phase behavior as a function of temperature and composition.

Scientific data·2025
Same author

Beyond the Beam: Redefining Survivorship in Prostate Cancer.

International journal of radiation oncology, biology, physics·2025
Same author

Modeling Contact Angles with Chemically Specific Dissipative Particle Dynamics.

Langmuir : the ACS journal of surfaces and colloids·2025
Same author

Prospective Evaluation of Supplemental External Beam Radiation Therapy With Palladium-103 Prostate Brachytherapy: Long-Term Results of the 44/20/0 Trials.

Practical radiation oncology·2024
Same author

Can Machine Learning Predict the Phase Behavior of Surfactants?

The journal of physical chemistry. B·2023

Area of Science:

  • Oncology
  • Urology
  • Radiation Medicine

Background:

  • Brachytherapy is a common treatment for early-stage prostate cancer.
  • Erectile function preservation is a key concern for patients undergoing prostate cancer treatment.
  • Historically, brachytherapy was considered favorable for preserving erectile function.

Purpose of the Study:

  • To evaluate the actual incidence of erectile dysfunction (ED) following brachytherapy for early-stage prostate cancer.
  • To identify clinical, treatment, and dosimetric factors associated with brachytherapy-induced ED.
  • To assess the efficacy of oral erectogenic agents in managing brachytherapy-related ED.

Main Methods:

  • Review of recent studies investigating outcomes after brachytherapy for prostate cancer.

Related Experiment Videos

  • Analysis of clinical, treatment, and dosimetric parameters in relation to erectile function.
  • Evaluation of patient response to oral erectogenic agents for post-brachytherapy ED.

    • Main Results:

    • Brachytherapy-related erectile dysfunction is more prevalent than previously reported.
    • Pre-implant erectile function and radiation dose to the proximal penis are significant predictors of ED.
    • The majority of patients experiencing brachytherapy-induced ED showed positive responses to oral erectogenic agents.

    Conclusions:

    • Brachytherapy can lead to a higher incidence of erectile dysfunction than assumed.
    • Patient's baseline erectile function and radiation dosimetry are critical factors in ED development.
    • Oral erectogenic agents offer an effective treatment option for brachytherapy-induced erectile dysfunction.